News | Nuclear Imaging | November 16, 2015

GE Features Latest Molecular Imaging Technology at RSNA 2015

Discovery IQ with Q.Clear technology and Discovery NM/CT 670 Pro with Q.Suite for SPECT/CT imaging highlight offerings

GE Healthcare, molecular imaging, PET/CT, Discovery IQ, Discovery NM/CT 670 Pro, RSNA 2015

Discovery IQ PET/CT scanner image courtesy of GE Healthcare


November 16, 2015 — GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission tomography/computed tomography (PET/CT) platform at this year’s Radiological Society of North America (RSNA) annual meeting, delivering both outstanding image quality and intelligent quantitation. According to the company, Discovery IQ delivers the highest NEMA (National Electrical Manufacturers Association) sensitivity (up to 22 cps/kBq), the largest axial field-of-view (up to 26 cm) and the highest clinical NECR (Noise-Equivalent-Count-Rate) in the industry. Discovery IQ can image with both half the PET dose and half the scan time.

GE Healthcare’s new Q.Clear technology is a critical component of Discovery IQ. It delivers, for the first time, no trade-off between image quality and quantitative standardized uptake value (SUV) measurements. By providing two times improvement in both quantitative accuracy (SUVmean) and image quality (signal-to-noise ratio) in PET/CT imaging, this tool provides benefits to physicians across the cancer care continuum from diagnosis and staging disease to treatment planning and assessment.

GE will also be showcasing the Discovery NM/CT 670 Pro, which brings cutting-edge CT technology to nuclear medicine by now integrating with GE’s Optima CT540. It combines  50-slice equivalent CT speed for extended fast coverage of time-critical scans with advanced CT applications; dose management tools such as OptiDose, DoseWatch and ASiR; and a streamlined workflow for challenging stand-alone CT procedures.

Discovery NM/CT 670 Pro also features GE’s Q.Suite for single photon emission computed tomography (SPECT)/CT technologies. Two elements of Q.Suite for SPECT/CT are Q.AC and GE’s newest software innovation in nuclear medicine, Q.Metrix. Q.Metrix, a user-friendly application for measuring and reporting standard uptake values in the organ or lesion of interest, enables personalized, quantitative SPECT SUV results with multi-dimensional organ and lesion characterization. Q.AC is an image reconstruction technique designed to help improve accuracy of SPECT attenuation correction that enables quantitative SPECT measurements even at very low dose.

For more information: www.gehealthcare.com


Related Content

News | Nuclear Imaging

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

Home August 03, 2023
Home
News | Nuclear Imaging

January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of ...

Home January 05, 2023
Home
News | Nuclear Imaging

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Home April 13, 2022
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D., MASNC, FASE, FSCCT, director of cardiac ...

Home February 01, 2022
Home
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Home June 02, 2021
Home
News | Nuclear Imaging

April 1, 2021 – The ability to measure myocardial blood flow (MBF) as part of myocardial perfusion imaging (MPI) is one ...

Home April 01, 2021
Home
News | Nuclear Imaging

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Subscribe Now